Welcome to LookChem.com Sign In|Join Free
  • or
N-butyl-5-nitro-2-(2-propynyloxy)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

68505-93-1

Post Buying Request

68505-93-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68505-93-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 68505-93-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,5,0 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 68505-93:
(7*6)+(6*8)+(5*5)+(4*0)+(3*5)+(2*9)+(1*3)=151
151 % 10 = 1
So 68505-93-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H16N2O4/c1-3-5-8-15-14(17)12-10-11(16(18)19)6-7-13(12)20-9-4-2/h2,6-7,10H,3,5,8-9H2,1H3,(H,15,17)

68505-93-1Relevant academic research and scientific papers

Synthesis of benzamide derivatives and their evaluation as antiprion agents

Fiorino, Ferdinando,Eiden, Martin,Giese, Armin,Severino, Beatrice,Esposito, Antonella,Groschup, Martin H.,Perissutti, Elisa,Magli, Elisa,Incisivo, Giuseppina Maria,Ciano, Antonio,Frecentese, Francesco,Kretzschmar, Hans A.,Wagner, Jens,Santagada, Vincenzo,Caliendo, Giuseppe

experimental part, p. 5001 - 5011 (2012/09/22)

A new set of 5-(2-(pyrrolidin-1-yl)acetamido)-N-butyl-2-(substituted) benzamide and 5-(2-(piperidin-1-yl)acetamido)-N-butyl-2-(substituted) benzamide derivatives were synthesized in which as structural features the 2-(1-pyrrolidinyl)- or 2-(1-piperidyl)acetylamino group or a diphenylether moiety are associated to a benzamide scaffold. Their binding affinity for human PrPC and inhibition of its conversion into PrPSc were determined in vitro; moreover, the antiprion activity was assayed by inhibition of PrPSc accumulation in scrapie-infected mouse neuroblastoma cells (ScN2a) and scrapie mouse brain (SMB) cells. The results clearly indicate the benzamide derivatives as attractive lead compounds for the development of potential therapeutic agents against prion disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 68505-93-1